{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T01:43:02Z","timestamp":1771033382167,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jsat.2019.08.015","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T11:45:46Z","timestamp":1566992746000},"page":"73-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Pre-exposure prophylaxis awareness and interest among participants in a medications for addiction treatment program in a unified jail and prison setting in Rhode Island"],"prefix":"10.1016","volume":"106","author":[{"given":"Meghan","family":"Peterson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandria","family":"Macmadu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley Q.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josiah","family":"Rich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Pognon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Lurie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer G.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Brinkley-Rubinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"151","key":"10.1016\/j.jsat.2019.08.015_bb0005","doi-asserted-by":"crossref","first-page":"151ra125","DOI":"10.1126\/scitranslmed.3004006","article-title":"Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men","volume":"4","author":"Anderson","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.jsat.2019.08.015_bb0010","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral prophylaxis for HIV prevention in heterosexual men and women","volume":"367","author":"Baeten","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jsat.2019.08.015_bb0015","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11904-018-0394-z","article-title":"Opioid use among those who have criminal justice experience: Harm reduction strategies to lessen HIV risk","volume":"15","author":"Brinkley-Rubinstein","year":"2018","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"12","key":"10.1016\/j.jsat.2019.08.015_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205593","article-title":"Knowledge, interest, and anticipated barriers of pre-exposure prophylaxis uptake and adherence among gay, bisexual, and men who have sex with men who are incarcerated","volume":"13","author":"Brinkley-Rubinstein","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jsat.2019.08.015_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.06.016","article-title":"The benefits and implementation challenges of the first state-wide comprehensive medication for addictions program in a unified jail and prison setting","author":"Brinkley-Rubinstein","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jsat.2019.08.015_bb0030","series-title":"Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142017 update: A clinical practice guideline","author":"Centers for Disease Control and Prevention","year":"2018"},{"issue":"9883","key":"10.1016\/j.jsat.2019.08.015_bb0035","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0140-6736(13)61127-7","article-title":"Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): A randomised, double-blind, placebo-controlled phase 3 trial","volume":"381","author":"Choopanya","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jsat.2019.08.015_bb0040","series-title":"Oral presentation. 12th international conference on HIV treatment and prevention adherence, Miami, FL","article-title":"\u201cWe need this!\u201d PrEP awareness and acceptability among women involved in the criminal justice system","author":"Dauria","year":"2017"},{"issue":"5","key":"10.1016\/j.jsat.2019.08.015_bb0045","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s10461-014-0867-z","article-title":"Acceptability of HIV pre-exposure prophylaxis (PrEP) among people who inject drugs (PWID) in a Canadian setting","volume":"19","author":"Escudero","year":"2015","journal-title":"AIDS Behav."},{"key":"10.1016\/j.jsat.2019.08.015_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.drugalcdep.2014.05.011","article-title":"A randomized controlled trial of prison-initiated buprenorphine: Prison outcomes and community treatment entry","volume":"142","author":"Gordon","year":"2014","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"10.1016\/j.jsat.2019.08.015_bb0055","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","article-title":"Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: A cohort study","volume":"14","author":"Grant","year":"2014","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"10.1016\/j.jsat.2019.08.015_bb0060","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/add.13437","article-title":"\u2018PrEP is not ready for our community, and our community is not ready for PrEP\u2019: Pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response","volume":"112","author":"Guise","year":"2017","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.jsat.2019.08.015_bb0065","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s10461-015-1055-5","article-title":"Sexual behavior, risk compensation, and HIV prevention strategies among participants in the San Francisco PrEP demonstration project: A qualitative analysis of counseling notes","volume":"20","author":"Hojilla","year":"2016","journal-title":"AIDS Behav."},{"issue":"2","key":"10.1016\/j.jsat.2019.08.015_bb0075","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11524-010-9538-1","article-title":"Dissolution of primary intimate relationships during incarceration and implications for post-release HIV transmission","volume":"88","author":"Khan","year":"2011","journal-title":"J. Urban Health"},{"issue":"9915","key":"10.1016\/j.jsat.2019.08.015_bb0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0140-6736(14)60137-9","article-title":"Uptake of PrEP for HIV slow among MSM","volume":"383","author":"Kirby","year":"2014","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.jsat.2019.08.015_bb0085","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/10509674.2018.1549180","article-title":"The TCU drug screen 5: Identifying justice-involved individuals with substance use disorders","volume":"57","author":"Knight","year":"2018","journal-title":"J. Offender Rehabil."},{"key":"10.1016\/j.jsat.2019.08.015_bb0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.drugalcdep.2016.02.044","article-title":"Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC","volume":"164","author":"Kuo","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"25.10","key":"10.1016\/j.jsat.2019.08.015_bb0095","first-page":"1","article-title":"HIV in prisons, 2001\u20132010","volume":"20","author":"Maruschak","year":"2012","journal-title":"AIDS"},{"issue":"9651","key":"10.1016\/j.jsat.2019.08.015_bb0100","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0140-6736(08)61311-2","article-title":"Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review","volume":"372","author":"Mathers","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jsat.2019.08.015_bb0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/QAI.0000000000001579","article-title":"Evolving models and ongoing challenges for HIV pre-exposure prophylaxis implementation in the United States","volume":"77","author":"Mayer","year":"2018","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jsat.2019.08.015_bb0110","doi-asserted-by":"crossref","unstructured":"Metzger, D. S., Donnell, D., Celentano, D. D., Jackson, J. B., Shao, Y., Aramrattana, A., \u2026 & Chawarski, M. (2015). Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV prevention trials network 058 (HPTN 058). J. Acquir. Immune Defic. Syndr., 68(5), 554.","DOI":"10.1097\/QAI.0000000000000510"},{"issue":"Suppl. 1","key":"10.1016\/j.jsat.2019.08.015_bb0115","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1097\/QAI.0b013e3181f9c10b","article-title":"Drug treatment as HIV prevention: A research update","volume":"55","author":"Metzger","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"2","key":"10.1016\/j.jsat.2019.08.015_bb0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/09540120802017586","article-title":"HIV, STD, and hepatitis risk behaviors of young men before and after incarceration","volume":"21","author":"Morrow","year":"2009","journal-title":"AIDS Care"},{"issue":"5","key":"10.1016\/j.jsat.2019.08.015_bb0125","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/QAD.0000000000001385","article-title":"Defining the HIV pre-exposure prophylaxis care continuum","volume":"31","author":"Nunn","year":"2017","journal-title":"AIDS (London, England)"},{"issue":"3","key":"10.1016\/j.jsat.2019.08.015_bb0130","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/09540121.2018.1524114","article-title":"Institutional distrust among gay, bisexual, and other men who have sex with men as a barrier to accessing pre-exposure prophylaxis (PrEP)","volume":"31","author":"Peterson","year":"2019","journal-title":"AIDS Care"},{"key":"10.1016\/j.jsat.2019.08.015_bb0135","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/183187","article-title":"An overview of HIV prevention interventions for people who inject drugs in Tanzania","volume":"2013","author":"Ratliff","year":"2013","journal-title":"Adv. Prev. Med."},{"issue":"9991","key":"10.1016\/j.jsat.2019.08.015_bb0140","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(14)62338-2","article-title":"Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: A randomised, open-label trial","volume":"386","author":"Rich","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jsat.2019.08.015_bb0145","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s11904-018-0396-x","article-title":"Integrated models of care for individuals with opioid use disorder: How do we prevent HIV and HCV?","volume":"15","author":"Rich","year":"2018","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"3","key":"10.1016\/j.jsat.2019.08.015_bb0150","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/QAI.0000000000001497","article-title":"Challenges in translating PrEP interest into uptake in an observational study of young black MSM","volume":"76","author":"Rolle","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jsat.2019.08.015_bb0155","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.drugalcdep.2018.08.014","article-title":"PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland","volume":"195","author":"Sherman","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"10.1016\/j.jsat.2019.08.015_bb0160","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s10461-016-1650-0","article-title":"Willingness to use pre-exposure prophylaxis (PrEP): An empirical test of the information-motivation-behavioral skills (IMB) model among high-risk drug users in treatment","volume":"21","author":"Shrestha","year":"2017","journal-title":"AIDS Behav."},{"key":"10.1016\/j.jsat.2019.08.015_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2018.00195","article-title":"Exploring the use of pre-exposure prophylaxis (PrEP) for HIV prevention among high-risk people who use drugs in treatment","volume":"6","author":"Shrestha","year":"2018","journal-title":"Front. Public Health"},{"issue":"9","key":"10.1016\/j.jsat.2019.08.015_bb0175","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1007\/s10461-014-0778-z","article-title":"Willingness to use HIV pre-exposure prophylaxis among opiate users","volume":"18","author":"Stein","year":"2014","journal-title":"AIDS Behav."},{"key":"10.1016\/j.jsat.2019.08.015_bb0180","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jcv.2015.12.011","article-title":"Performance of determine combo and other point-of-care HIV tests among Seattle MSM","volume":"76","author":"Stekler","year":"2016","journal-title":"J. Clin. Virol."},{"issue":"2","key":"10.1016\/j.jsat.2019.08.015_bb0185","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1098214005283748","article-title":"A general inductive approach for analyzing qualitative evaluation data","volume":"27","author":"Thomas","year":"2006","journal-title":"Am. J. Eval."},{"issue":"7","key":"10.1016\/j.jsat.2019.08.015_bb0190","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s10508-017-1100-8","article-title":"Temporal fluctuations in behavior, perceived HIV risk, and willingness to use pre-exposure prophylaxis (PrEP)","volume":"47","author":"Underhill","year":"2018","journal-title":"Arch. Sex. Behav."},{"issue":"1","key":"10.1016\/j.jsat.2019.08.015_bb0200","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12954-017-0166-x","article-title":"Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: The importance of networks and syringe exchange programs for HIV prevention","volume":"14","author":"Walters","year":"2017","journal-title":"Harm Reduct. J."},{"issue":"5","key":"10.1016\/j.jsat.2019.08.015_bb0205","first-page":"359","article-title":"HIV and mass incarceration: Where infectious diseases and social justice meet","volume":"77","author":"Wohl","year":"2016","journal-title":"N. C. Med. J."},{"key":"10.1016\/j.jsat.2019.08.015_bb0210","series-title":"Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV, web supplement: Annex 2: Evidence to decision-making tables and supporting evidence (no. WHO\/HIV\/2015.36)","author":"World Health Organization","year":"2015"},{"issue":"41","key":"10.1016\/j.jsat.2019.08.015_bb0215","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.15585\/mmwr.mm6741a3","article-title":"HIV preexposure prophylaxis, by race and ethnicity\u2014United States, 2014\u20132016","volume":"67","author":"Ya-lin","year":"2018","journal-title":"Morb. Mortal. Wkly Rep."},{"issue":"2","key":"10.1016\/j.jsat.2019.08.015_bb0220","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jsat.2013.02.005","article-title":"Initiation of buprenorphine during incarceration and retention in treatment upon release","volume":"45","author":"Zaller","year":"2013","journal-title":"J. Subst. Abus. Treat."}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219301643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547219301643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:50:37Z","timestamp":1760039437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547219301643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":41,"alternative-id":["S0740547219301643"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2019.08.015","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pre-exposure prophylaxis awareness and interest among participants in a medications for addiction treatment program in a unified jail and prison setting in Rhode Island","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2019.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}